Exo Booster Dermalogica® is an advanced regenerative therapy using exosomal signaling factors and substances that support skin regeneration, developed in the spirit of modern regenerative medicine and biohacking. The treatment is aimed at improving skin quality, supporting repair processes and optimizing the cellular environment—without a volumizing effect.

The therapy is biological and supportive. It may be used as a standalone procedure or as part of combined protocols.

Mechanism of action

After application of Exo Booster Dermalogica®:

• exosomal signaling factors initiate intercellular communication,
• fibroblast activity and other skin-cell activity is modulated,
• tissue regeneration and remodeling processes are supported,
• the cellular microenvironment of the skin is improved,
• inflammatory response is regulated.

The effect is functional and biological rather than mechanical.

Clinical significance

Exo Booster Dermalogica® may:

• support natural regenerative skin processes,
• improve skin structure, elasticity and overall quality,
• accelerate recovery after aesthetic procedures,
• increase the effectiveness of biostimulatory and regenerative therapies,
• fit the concepts of regenerative medicine and longevity.

Clinical indications

Therapy may be considered in patients:

• with reduced skin quality and density,
• with signs of biological aging,
• after aesthetic procedures as part of recovery,
• with signs of oxidative stress and skin fatigue,
• seeking modern, biological supportive therapies.

Most common areas:

• face,
• neck,
• decolletage.

Therapy profile

• individually planned,
• may be used as a standalone procedure or as part of combined therapy,
• no volumizing effect,
• short or minimal downtime.

Therapy is performed based on proprietary clinical protocols developed from current medical knowledge and practical experience.

Dr. Mariusz Borkowski is a physician collaborating with the Dermalogica brand as an expert and representative of Exo Booster Dermalogica® under a formal agreement. His role includes participation in medical education, trainings and development of therapeutic protocols in skin regeneration.

Medical information

Exo Booster Dermalogica® should be performed after medical qualification. The therapy is supportive of regenerative processes and does not replace medical treatment.

Exo Booster Dermalogica® is part of a modern approach to skin regeneration based on biological cellular signaling and evidence-based medicine.